Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Symonds

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 19, 2013
Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis CR J Fontana, E A Hughes, M Bifano, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2007
Safety and pharmacokinetics of GSK364735, a human immunodeficiency virus type 1 integrase inhibitor, following single and repeated administration in healthy adult subjectsY Sunila Reddy, Sherene S Min, Julie Borland, et al.
International Journal of Impotence Research|June 15, 2007
Further evidence of the reliability and validity of the premature ejaculation diagnostic toolT Symonds, M Perelman, S Althof, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
In vitro-in vivo model for evaluating the antiviral activity of amprenavir in combination with ritonavir administered at 600 and 100 milligrams, respectively, every 12 hoursSandra L Preston, Peter J Piliero, John A Bilello, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2012
Pharmacokinetics, pharmacodynamics, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor, following multiple ascending doses in patients with chronic hepatitis C infectionEric Lawitz, Maribel Rodriguez-Torres, Jill M Denning, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Pharmacodynamics of abacavir in an in vitro hollow-fiber model systemG L Drusano, P A Bilello, W T Symonds, et al.
International Journal of Clinical Practice|June 29, 2010
Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative researchK S Coyne, C C Sexton, Z Kopp, et al.
Journal of Viral Hepatitis|March 28, 2008
Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymeraseC L Ward, A Dev, S Rigby, et al.
Pharmacotherapy|January 1, 1997
Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteersD E Nix, W T Symonds, J M Hyatt, et al.
BMC Musculoskeletal Disorders|May 20, 2017
Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17): part 2 psychometric evaluation in fibromyalgia patientsY Li, S Morris, J Cole, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 19, 2013
Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis CR J Fontana, E A Hughes, M Bifano, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2007
Safety and pharmacokinetics of GSK364735, a human immunodeficiency virus type 1 integrase inhibitor, following single and repeated administration in healthy adult subjectsY Sunila Reddy, Sherene S Min, Julie Borland, et al.
International Journal of Impotence Research|June 15, 2007
Further evidence of the reliability and validity of the premature ejaculation diagnostic toolT Symonds, M Perelman, S Althof, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
In vitro-in vivo model for evaluating the antiviral activity of amprenavir in combination with ritonavir administered at 600 and 100 milligrams, respectively, every 12 hoursSandra L Preston, Peter J Piliero, John A Bilello, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2012
Pharmacokinetics, pharmacodynamics, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor, following multiple ascending doses in patients with chronic hepatitis C infectionEric Lawitz, Maribel Rodriguez-Torres, Jill M Denning, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Pharmacodynamics of abacavir in an in vitro hollow-fiber model systemG L Drusano, P A Bilello, W T Symonds, et al.
International Journal of Clinical Practice|June 29, 2010
Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative researchK S Coyne, C C Sexton, Z Kopp, et al.
Journal of Viral Hepatitis|March 28, 2008
Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymeraseC L Ward, A Dev, S Rigby, et al.
Pharmacotherapy|January 1, 1997
Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteersD E Nix, W T Symonds, J M Hyatt, et al.
BMC Musculoskeletal Disorders|May 20, 2017
Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17): part 2 psychometric evaluation in fibromyalgia patientsY Li, S Morris, J Cole, et al.
Pageof 7